Popular Articles

New Online Curriculum Educates Physicians About Kidney Disease In Older Patients
The fastest-growing group of patients initiating dialysis is patients 75 years old and older; providing the best care for this group of patients presents significant challenges. The American Society of Nephrology (ASN) introduces the first-ever online curriculum to address aging and the kidney. The curriculum, based on the Accreditation Council for Graduate Medical Education (ACGME)"s six core competences of patient care, medical knowledge, practice-based learning and improvement, interpersonal and communication skills, professionalism, and systems-based practice, answers questions about the management of elderly patients.
generic viagra
Opinion: Second-Line ARVs In India; PEPFAR Funding
Access To Second-Line Antiretrovirals In India
News of the day
GlaxoSmithKline And Genmab Announce Top-line Results For Ofatumumab In Rheumatoid Arthritis
GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) announced preliminary top-line results from a Phase III study of ofatumumab administered intravenously for the treatment of rheumatoid arthritis (RA) in patients who had an inadequate response to methotrexate. The study met the primary endpoint, ACR20 at 24 weeks, which indicates a 20 percent or greater improvement in the number of swollen and tender joints, as well as improvements in other disease-activity measures.
Public Health

Confirmed Link Between Chronic Infection And Immune-System Protein

The reason deadly infections like human immunodeficiency virus (HIV) and hepatitis C never go away is because these viruses disarm the body"s defense system. Researchers at the University of Alabama at Birmingham (UAB) have discovered that a key immunity protein must be present for this defense system to have a chance against chronic infection. Research up to now has tried but failed to decipher the cross-talk between "killer T-cells" and "helper T-cells" in the fight against viruses. The new UAB study finds this cross-talk can only happen in the presence of interleukin-21, a powerful immune system protein. If interleukin-21 is missing for whatever reason, then the immune system"s anti-viral efforts fail, said Allan Zajac, Ph.D., an associate professor in UAB"s Department of Microbiology and lead author on the study. The findings are published in the journal Science through its Science Express service. "Adding interleukin-21 back in stimulates the immune response and controls the infection," Zajac said. "We demonstrate that the loss of this protein prevents the control of the infection and diminishes the function of the killer T-cells, specifically CD8 T-cells." The study mice were treated for lymphocytic choriomeningitis, a viral infection of the membranes surrounding the brain and spinal cord. Measurements were taken for two types of T-cells, CD4 and CD8 T-cells, before and after the mice were treated with interleukin-21. "Interleukin-21 served as the key messenger between the T-cells, whereas before we didn"t know exactly how the two types of cells communicated with each other," Zajac said. The CD4 T-cells help the immune system do its job by boosting CD8 T-cells" ability to fight and kill viruses. Co-authors on the study include John Yi and Ming Du, Ph.D., both of UAB"s Department of Microbiology. Research funds came from the National Institutes of Health. Troy Goodman University of Alabama at Birmingham


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):